Effect of cypermethrin on memory, movement activity and co-ordination in mice after transient incomplete cerebral ischemia

Pharmacological Reports

Volumn 60, Issue 5, 2008, Pages 699-705

  Nieradko Iwanicka, Barbara ^a   Borzecki, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Cypermethrin; Memory; Movement activity; Movement co ordination; Transient cerebral ischemia

Indexed keywords

CIPERMETHRIN; DRINKING WATER; KETAMINE; PESTICIDE RESIDUE; XYLAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; LD 50; MAZE TEST; MEMORY CONSOLIDATION; MOTION; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; NEUROTOXICITY; NONHUMAN; PASSIVE AVOIDANCE; SPATIAL MEMORY; TOXICITY TESTING; WORKING MEMORY;

EID: 57849094499     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Adler CM, Goldberg TE, Malhotra AK, Pickar D, Breier A: Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatry, 1998, 43, 811-816.
2. Allen DG, Dyson DH, Pascoe PJ, O'Grady MR: Evaluation of a xylazine-ketamine hydrochloride combination in the cat. Can J Vet Res, 1986, 50, 23-26.
3. Badach H, Nazimek T, Kamińska IA: Pesticide content in drinking water samples collected from orchard areas in central Poland. Ann Agric Environ Med, 2007, 14, 109-114.
4. Baniadam A, Afshir FS, Balani MB: Cardiopulmonary effects of acepromazine-ketamine administration in the sheep. Bull Vet Inst Pulawy, 2007, 51, 93-96.
5. Bischoff C, Tiedtke PI: Competitive and non-competitive NMDA receptor antagonists in spatial learning tasks. Eur J Pharmacol, 1992, 213,269-273.
6. Casco VH, Izaguirre MF, Marin L, Vergara MN, Lajmanovich RC, Peltzer P: Apoptotic cell death in the central nervous system of Bufo arenarum tadpoles induced by cypermethrin. Cell Biol Toxicol, 2006, 22, 199-211.
7. Chen SY, Zhang ZW, He FS, Yao PP, Wu YQ, Sun JX, Liu LH et al.: An epidemiologic-study on occupational acute pyrethroid poisoning in cotton farmers. Br J Ind Med, 1991, 48, 77-81.
8. Fortin MC, Bouchard M, Carrier G, Dumas P: Biological monitoring of exposure to pyrethrins and pyrethroids in a metropolitan population of the Province of Quebec, Canada. Environ Res, 2008, 107, 343-350.
9. Ginsberg MD, Takagi K, Globus MY-T: Release of neurotransmitters in cerebral ischemia: relevance to neuronal injury. In: Pharmacology of Cerebral Ischemia. Ed. Krieglstein J, Oberpilcher-Schwenk H, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 1992, 177-190.
10. He FS, Wang SG, Liu LH, Chen SY, Zhang ZW, Sun JX: Clinical manifestations and diagnosis of acute pyrethroid poisoning. Arch Toxicol, 1989, 63, 54-58.
11. Heim C, Sieklucka M, Block F, Schmidt-Kastner R, Jaspers R, Sontag K-H: Transient occlusion of carotid arteries leads to disturbed spatial learning and memory in the rat. In: Pharmacology of Cerebral Ischemia. Ed. Krieglstein J, Oberpilcher H, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 1990, 53-61.
12. Heim C, Zhang J, Lan J, Sieklucka M, Kurz T, Riederer P, Gerlach M, Sontag K-H: Cerebral oligaemia episode triggers free radical formation and late cognitive deficiencies. Eur J Neurosci, 2000, 12, 715-725.
13. Heyer EJ, DeLaPaz R, Halazun HJ, Rampersad A, Sciacca R, Zurica J, Benvenisty AI et al.: Neuropsychological dysfunction in the absence of structural changes in patients with cerebral ischemia after uncomplicated endarterectomy. Neurosurgery, 2006, 58, 474-480.
14. Jóźwiak L, Łukawski K, Czuczwar SJ, Sieklucka-Dziuba M: Competitive NMDA receptor antagonists and agonists: effect on spontaneous alteration in mice exposed to cerebral oligemia. Pol J Pharmacol, 2004, 56, 59-66.
15. Jóźwiak L. Łukawski K, Siekluelcka-Dziuba M: Cerebral oligemic hypoxia and MK-801 treatment: effect on alternation behavior in mice. Pharmacol Rep, 2006, 58, 770-773.
16. Khanna RN, Gupta GSD, Anand M: Kinetics and distribution of cypermethrin in blood, brain and spinal cord after single administration to rabbits. Bull Environ Contam Toxicol, 2002, 69, 749-755.
17. Klatz R: New horizons for the clinical speciality of anti-aging medicine. The future with biomedical technologies. Ann NY Acad Sci, 2005, 1057, 536-544.
18. Lichtfield JT, Wilcoxon F A: Simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther, 1949, 96, 99-113.
19. Łukawski K, Nieradko B, Sieklueka-Dziuba M: Effects of cadmium on memory processes in mice exposed to transient cerebral oligemia. Nerotoxicol Teratol, 2005, 27, 575-584.
20. Łukawski K, Sieklucka-Dziuba M: Effect of lead exposure on memory processes in mice after cerebral oligemia. Pharmacol Rep, 2007, 59, 691-698.
21. Maurice T, Su T-P, Parish W, Nabeshima T, Privat A: PRE-084, a σ PCP derivative, attenuates MK-801-induced impairment of learning in mice. Pharmacol Biochem Behav, 1994, 49, 859-869.
22. Moniz AC, Bernardi MM, Spinosa HS: Effects of a pyrethroid type-II pesticide on conditioned behaviors of rats. Vet Hum Toxicol, 1994, 36, 120-124.
23. Muir W, Skarda RT, Milne DW: Evaluation of xylazine and ketamine hydrochloride anesthesia in horses. Am J Vet Res, 1977, 38, 195-201.
24. Nelson CL, Burk JA, Bruno JP, Sarter M: Effects of acute and repeated administmtion of ketamine on prefrontal acetylcholine release and sustained attention performance in rats. Psychopharmacology, 2002, 161, 168-179.
25. Olney JW, Farber B: Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry, 1995, 52, 998-1007.
26. Pluta R: From brain ischemia-reperfusion injury to possible sporadic Alzheimer's disease. Curr Neurovasc Res, 2004, 1, 441-453.
27. Pluta R: Pathological opening of the blood-brain barrier to horseradish peroxidase and amyloid precursor protein following ischemia-reperfusion brain injury. Chemiotherapy, 2005, 51, 223-226.
28. Pluta R: Is the ischemic blood-brain barrier insufficiency responsible for the full-blown Alzheimer's disease? Neurol Res, 2006, 28, 665-671.
29. Pluta R: Is the ischemic blood-brain barrier a Trojan horse in Alzheimer's disease brain? In: Ischemia-Reperfusion, Pathways of Alzheimer's Disease. Ed. Pluta R, Nova Science Publishers, Hauppauge, New York, USA, 2007, 139-184.
30. Ray DE: Pyrethroid insecticides: mechanisms of toxicity, systemic poisoning syndromes, paresthesia, and therapy. In: Handbook of Pesticide Toxicology, 2nd edn. Ed. Krieger R, Academic Press, USA, 2001, 2, 1289-1303.
31. Ray DE: The contrasting actions of two pyrethroids (deltamethrin and cismethrin) in the rat. Neurobehav Toxicol Teratol, 1982, 4, 801-804.
32. Sadło S, Szpyrka E, Rogozińska K, Rupar J, Kuźmenko A: Occurrence of pesticide residues in raspberries in 2000-2005 (Polish). Rocz Panstw Zakl Hig, 2007, 58, 509-513.
33. Sadowski M, Łazarewiez JW, Jakubowska-Sadowska K, Wiśniewski HM, Mossakowski M J, Brown WT: Long-term changes in calbindin D (28K) immunoreactivity in the rat hippocampus after cardiac arrest. Neurosci Lett, 2002, 321, 90-94.
34. Salfizadeh S, Pourjafar M, Naghadeh B, Jalali FSS: Caudal extradural analgesia with lidocaine, xylazine, and a combination of lidocaine and xylazine in the Iranian river buffalo. Bull Vet Inst Pulawy, 2007, 51, 285-288.
35. Sieklucka M, Heim C, Block F, Sontag K-H: Transient reduction of cerebral blood flow leads to long-lasting increase in GABA content in vulnerable structures and decreased susceptibility to bicuculline induced seizures. J Neural Transm, 1992, 88, 87-94.
36. Soderlund DM, Clark JM, Sheets LP, Mullin LS, Piccirillo VJ, Sargent D, Stevens JT et al.: Mechanisms of pyrethroid neurotoxicity: implications for cumulative risk assessment. Toxicology, 2002, 171, 3-59.
37. Song JH, Narahashi T: Differential effects of the pyrethroid tetramethrin on tetrodotoxin-sensitive and tetrodotoxin-resistant single sodium channels. Brain Res, 1996, 712, 258-264.
38. Song JH, Narahashi T: Modulation of sodium channels of rat cerebellar Purkinje neurons by the pytrethroid tetramethrin. J Pharmacol Exp Ther, 1996, 277, 445-453.
39. Sontag K-H, Heim C, Block F, Sieklucka M, Schmidt-Kastner R, Melzacka M, Osborne N et al.: Cerebral oligemic hypoxia and forebrain ischemia common and different long-lasting consequences. In: Pharmacology of Cerebral Ischemia. Ed. Krieglstein J, Oberpilcher-Schwenk H, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 1992, 471-479.
40. Stephenson J, Blevins DI, Christie G: Safety of Rompun/Ketaset combination in dogs. Vet Med Small Anim Clin, 1978, 73, 303-305.
41. Venault P, Chapouthier G, Prado de Carvalho L, Simiand J, Morre M, Dodd RH, Rossier J: Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks. Nature, 1986, 321, 864-866.
42. Warmke JW, Reenan RAG, Wang PY, Qian S, Arena JP, Wang JX, Wundelel D et al.: Functional expression of Drosophila para sodium cannels - modulation by the membrane protein TipE and toxin pharmacology. J Gen Physiol, 1997, 110, 119-133.
43. Wolff M, Benhassine N, Costet P, Hen R, Segu L, Buhot MC: a Delay-dependent working memory impairment in young-adult and aged 5-HTIBKO mice as assessed in a radial-arm water maze. Learn Mem, 2003, 10, 401-409.
44. Zlokovic BV: The blood-brain bartier in health and chronic neurodegenemtive disorders. Neuron, 2008, 57, 178-201.